President John Dramani Mahama has named Professor Kwabena Frimpong-Manso Opuni as the new acting Chief Executive Officer of the Food and Drugs Authority (FDA), effective Monday, July 14, 2025.
In a post shared on its official social media pages, the FDA announced that Opuni will take over from Delese Darko, who served as Chief Executive Officer from 2017 until her recent appointment as Director-General of the Africa Medicines Agency (AMA).
FDA expressed gratitude to Darko for her years of committed service, highlighting her contributions to strengthening regulatory frameworks, enhancing public safety, and fostering international partnerships.
Her new role at the AMA is widely seen as recognition of her outstanding leadership in the regulatory health sector.
The Authority extended its congratulations to Professor Opuni on his new appointment and affirmed its full confidence in his capability to lead the FDA in its core mission of protecting public health through the regulation of food, medicines, and other related products.
”The FDA extends its warmest congratulations to Prof. Opuni on his appointment & looks forward to his leadership in advancing the Authority’s mandate of safeguarding public health & safety” it stated.
With a background in pharmaceutical analysis and public health policy, he is expected to strengthen the FDA’s regulatory systems, enhance stakeholder collaboration, and drive innovation in ensuring the safety and quality of products on the Ghanaian market.
DR/MA
Meanwhile, you can watch GhanaWeb TV’s exclusive interview with Arathejay below: